01 1Sun Pharmaceutical Industries Limited
01 1ATAZANAVIR SULFATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-23
Pay. Date : 2017-01-05
DMF Number : 31229
Submission : 2017-03-07
Status : Active
Type : II
20
Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ATAZANAVIR SULFATE, with a corresponding US DMF Number 31229.
Remarkably, this DMF maintains an Active status since its submission on March 07, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 23, 2017, and payment made on January 05, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
